Home › Calculator › MTNB Dividend Calculator 2026
MTNB Dividend Calculator 2026
No dividendHealthcareMatinas BioPharma Holdings, Inc. · AMEX
Price: $1.70 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
MTNB is not a dividend-focused stock
MTNB pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
MTNB Dividend Yield
Matinas BioPharma Holdings, Inc. (MTNB) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MTNB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Matinas BioPharma Holdings, Inc. (MTNB) — Dividend Analysis 2026
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its primary experimental drug, LYPDISO, is a proprietary, prescription-grade omega-3 free fatty acid compound engineered to address cardiovascular and metabolic disorders. Matinas BioPharma is also advancing MAT2203, an orally administered version of amphotericin B. This candidate is currently in Phase II clinical trials, where it is being evaluated for its ability to prevent invasive fungal infections in patients undergoing immunosuppressive treatment. Furthermore, MAT2501, an oral formulation of the broad-spectrum aminoglycoside antibiotic amikacin, has successfully completed Phase I clinical trials. Its aim is to combat a spectrum of multidrug-resistant bacterial infections, such as non-tuberculous mycobacterium, multidrug-resistant gram-negative, and intracellular bacterial pathogens. The company actively engages in collaborations, including a research partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to further the development of Gilead's antiviral drug, remdesivir. Additionally, it has a feasibility collaboration with Genentech, Inc. focused on creating new oral drug formulations. Established in 2013, Matinas BioPharma maintains its corporate headquarters in Bedminster, New Jersey.
MTNB Dividend & DRIP — Frequently Asked Questions
Does MTNB pay a dividend?
No. Matinas BioPharma Holdings, Inc. (MTNB) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of MTNB?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does MTNB have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. MTNB has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to MTNB
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MTNB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MTNB position with:
🌍 MTNB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MTNB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MTNB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MTNB Dividend Payment Schedule
MTNB pays quarterly — 4 times per year. Ex-div: —.
📊 MTNB vs Healthcare Benchmarks
How MTNB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MTNB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MTNB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| J-Other | 2025-10-16 | 800,000 | $0.64 | $515.7K | ||
| X-InTheMoney | 2026-07-10 | 630,335 | $0.35 | $220.6K | ||
| A-Award | 2026-07-10 | 630,335 | $0.35 | $220.6K | ||
| X-InTheMoney | 2025-10-31 | 92,100 | $0.64 | $59.4K | ||
| X-InTheMoney | 2026-07-10 | 344,710 | $0.35 | $120.6K | ||
| A-Award | 2026-07-10 | 344,710 | $0.35 | $120.6K | ||
| J-Other | 2026-07-10 | 141,462 | $0.35 | $49.5K | ||
| X-InTheMoney | 2025-10-31 | 92,100 | $0.64 | $59.4K | ||
| J-Other | 2025-10-16 | 265 | $0.59 | $155.00 | ||
| X-InTheMoney | 2026-07-10 | 344,710 | $0.35 | $120.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare MTNB with peers: MTNB vs ACXP · MTNB vs ADIL · MTNB vs ADXN
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MTNB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Matinas BioPharma Holdings, Inc. (MTNB) is currently trading at $1.70, 93% below its 52-week high. It does not currently pay a regular dividend.
Does MTNB Pay a Dividend? Matinas BioPharma Holdings, Inc. Dividend Status
Matinas BioPharma Holdings, Inc. (MTNB) is a healthcare stock trading at $1.70. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest MTNB News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your MTNB DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.